NEW YORK, NY / ACCESSWIRE / April 2, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.
LogicBio Therapeutics, Inc.(NASDAQ:LOGC)
Class Period: December 3, 2018 - February 10, 2020
Deadline: May 18, 2020
For more info:www.bgandg.com/logc
The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements that: (1) LogicBio Therapeutics, Inc.'s behind-schedule and rushed Investigational New Drug ("IND") submission of LB-001 did not answer certain pertinent clinical and nonclinical questions; (2) as a result, the U.S. Food and Drug Administration was likely to hold or deny the IND submission of LB-001 for treatment of methylmalonic acidemia (MMA); and (3) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Paysign, Inc. (NASDAQ:PAYS)
Class Period: March 12, 2019 - March 15, 2020
Deadline: May 18, 2020
For more info:www.bgandg.com/pays
The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements that: (1) Paysign's internal control over financial reporting was not effective; (2) Paysign's information technology general controls were not effective; and (3) as a result, defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Contact:
Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz
212-697-6484 | info@bgandg.com
SOURCE: Bronstein, Gewirtz & Grossman, LLC
View source version on accesswire.com:
https://www.accesswire.com/583043/LOGC-PAYS-INVESTOR-ALERT-Bronstein-Gewirtz-Grossman-LLC-Notifies-Investors-of-Class-Actions-and-Encourages-Investors-to-Contact-the-Firm
